ABOUT US
About AmoyDx History Certificates News & Events Staff Charisma Stock Information
PRODUCTS
NGS Assays Real-time PCR Assays FISH Assays Extraction
GLOBAL BUSINESS
Distributorship
SUPPORT
Customer Service
FAQs
DOWNLOAD
MEET US
MEET US
language
Search
2019-nCoV NTRK HRR HANDLE Classic NGS Panel Pan Lung Cancer Essential NGS panel BRCA Multi-Gene Super-ARMS EGFR C797S KRAS NRAS ROS1 MET HPV
Log in
Log in
Search
2019-nCoV NTRK HRR HANDLE Classic NGS Panel Pan Lung Cancer Essential NGS panel BRCA Multi-Gene Super-ARMS EGFR C797S KRAS NRAS ROS1 MET HPV
ABOUT US PRODUCTS GLOBAL BUSINESS SUPPORT MEET US
  • Better life with AmoyDx
    more
  • Better life with AmoyDx
    more
  • AmoyDx won the Second Prize of National Scientific and Technological Progress Award
    more
  • Better life with AmoyDx
    more
Scroll

ABOUT AMOYDX

Amoy Diagnostics Co., Ltd. (AmoyDx) focuses on molecular diagnostics for oncology precision medicine. With completely independent intellectual property rights of ADx-ARMS and Super-ARMS technologies, AmoyDx has a market-leading portfolio of molecular diagnostic kits including but not limited to EGFR, RAS, ALK, BRAF, PIK3CA and ROS1 testing kits, which were firstly approved by CFDA and CE certified. 

more
Better Life with AmoyDx

Latest News

Latest News more
04 /Sep

AmoyDx EGFR Detection Method Won the 21st China's Top Patent Award

The EGFR mutation detection method from AmoyDx (Application No.: ZL200910111499.2, Publication No.: CN101608240B) won the Silver Award of the 21st China Patent Award as recently announced by the China National Intellectual Property Administration (CNIPA).

27 /Aug

AmoyDx Collaborates with Haihe Pharmaceutical to Codevelop Companion Diagnostics for Japan Market

Xiamen, China, August 27, 2020– Amoy Diagnostics Co., Ltd. (AmoyDx, SZSE: 300685) announced that it signed an agreement with Haihe Pharmaceutical to develop a Companion Diagnostic (CDx) test supporting the novel MET inhibitor Glumetinib (SCC244). The CDx

10 /Aug

AmoyDx Collaborates with Merck KGaA, Darmstadt, Germany to Develop Companion Diagnostics for Japan Market

Xiamen, China, 9:00am, August 10, 2020– Amoy Diagnostics Co., Ltd. (AmoyDx, SZSE: 300685) announced that it signed an agreement with Merck KGaA, Darmstadt, Germany, to develop a Companion Diagnostic (CDx) test supporting the novel MET inhibitor tepotinib.

08 /Jul

AmoyDx Signs Agreement with AstraZeneca to Cooperate in Cancer Diagnosis in China

Xiamen, China, 8 July, 2020– Amoy Diagnostics Co., Ltd. (AmoyDx, SZSE: 300685) announced that recently it signed an agreement with AstraZeneca to work together closely for the molecular diagnosis of patients with cancer.

more

New Products

new product release

    New Products

    new product release

    • AmoyDx® Novel Coronavirus (2019-nCoV) Detection Kit

    • NTRK Gene Fusions Detection Kit

    • Pan Lung Cancer PCR Panel

    • HANDLE Classic NGS Panel

    • BRCA1 and BRCA2 Gene Mutation Detection Kit

    • AmoyDx® Virus Transport Medium

    • HANDLE HRR NGS Panel

    • AmoyDx® Virus/Cell RNA Kit

    • PCR AmoyDx® Novel Coronavirus (2019-nCoV) Detection Kit
      01
    • PCR NTRK Gene Fusions Detection Kit
      02
    • PCR Pan Lung Cancer PCR Panel
      03
    • NGS HANDLE Classic NGS Panel
      04
    • NGS BRCA1 and BRCA2 Gene Mutation Detection Kit
      05
    • Extraction AmoyDx® Virus Transport Medium
      06
    • NGS HANDLE HRR NGS Panel
      07
    • Extraction AmoyDx® Virus/Cell RNA Kit
      08
    1. 01
    2. 02
    3. 03
    4. 04
    5. 05
    6. 06
    7. 07
    8. 08

    • AmoyDx® Novel Coronavirus (2019-nCoV) Detection Kit

    • NTRK Gene Fusions Detection Kit

    • Pan Lung Cancer PCR Panel

    • HANDLE Classic NGS Panel

    • BRCA1 and BRCA2 Gene Mutation Detection Kit

    • AmoyDx® Virus Transport Medium

    • HANDLE HRR NGS Panel

    • AmoyDx® Virus/Cell RNA Kit

    • PCR AmoyDx® Novel Coronavirus (2019-nCoV) Detection Kit
      01
    • PCR NTRK Gene Fusions Detection Kit
      02
    • PCR Pan Lung Cancer PCR Panel
      03
    • NGS HANDLE Classic NGS Panel
      04
    • NGS BRCA1 and BRCA2 Gene Mutation Detection Kit
      05
    • Extraction AmoyDx® Virus Transport Medium
      06
    • NGS HANDLE HRR NGS Panel
      07
    • Extraction AmoyDx® Virus/Cell RNA Kit
      08
    1. 01
    2. 02
    3. 03
    4. 04
    5. 05
    6. 06
    7. 07
    8. 08

    • AmoyDx® Novel Coronavirus (2019-nCoV) Detection Kit

    • NTRK Gene Fusions Detection Kit

    • Pan Lung Cancer PCR Panel

    • HANDLE Classic NGS Panel

    • BRCA1 and BRCA2 Gene Mutation Detection Kit

    • AmoyDx® Virus Transport Medium

    • HANDLE HRR NGS Panel

    • AmoyDx® Virus/Cell RNA Kit

    • PCR AmoyDx® Novel Coronavirus (2019-nCoV) Detection Kit
      01
    • PCR NTRK Gene Fusions Detection Kit
      02
    • PCR Pan Lung Cancer PCR Panel
      03
    • NGS HANDLE Classic NGS Panel
      04
    • NGS BRCA1 and BRCA2 Gene Mutation Detection Kit
      05
    • Extraction AmoyDx® Virus Transport Medium
      06
    • NGS HANDLE HRR NGS Panel
      07
    • Extraction AmoyDx® Virus/Cell RNA Kit
      08
    1. 01
    2. 02
    3. 03
    4. 04
    5. 05
    6. 06
    7. 07
    8. 08

    • AmoyDx® Novel Coronavirus (2019-nCoV) Detection Kit

    • NTRK Gene Fusions Detection Kit

    • Pan Lung Cancer PCR Panel

    • HANDLE Classic NGS Panel

    • BRCA1 and BRCA2 Gene Mutation Detection Kit

    • AmoyDx® Virus Transport Medium

    • HANDLE HRR NGS Panel

    • AmoyDx® Virus/Cell RNA Kit

    • PCR AmoyDx® Novel Coronavirus (2019-nCoV) Detection Kit
      01
    • PCR NTRK Gene Fusions Detection Kit
      02
    • PCR Pan Lung Cancer PCR Panel
      03
    • NGS HANDLE Classic NGS Panel
      04
    • NGS BRCA1 and BRCA2 Gene Mutation Detection Kit
      05
    • Extraction AmoyDx® Virus Transport Medium
      06
    • NGS HANDLE HRR NGS Panel
      07
    • Extraction AmoyDx® Virus/Cell RNA Kit
      08
    1. 01
    2. 02
    3. 03
    4. 04
    5. 05
    6. 06
    7. 07
    8. 08
  1. NGS
  2. PCR
  3. FISH
  4. Extraction
    5. more
Support

World Conference on Lung Cancer 2020

https://wclc2020.iaslc.org/

January 26 – 29, 2021
meet us

AMP Annual(Association for Molecular Pathology) 2020

https://amp20.amp.org/

November 19-21, 2020

  • Stock Info

    Stock info
  • 76.510 +2.74 +3.71％
    Stock code：300685 2020-09-30 15:35:00 Real-time data
  • View details
Inquiry
* Required information
Refresh the image
send
Manage your account info
  • Please Select
  • Mr.
  • Ms.
  • Dr.
  • Prof.
Submit
Change your password
Confirm Submission